ST 198

ST 198 is an orally active D3R antagonist. ST 198 can block the expression of nicotine-induced CPP at doses selective for D3R. ST 198 can be used for the research of neurological disease[1].

Product Specifications

CAS Number

[854924-64-4]

UNSPSC

12352005

Target

Dopamine Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/st-198.html

Solubility

10 mM in DMSO

Smiles

O=C(NCCCCN1CC2=C(C=CC=C2)CC1)/C=C/C3=CC=CC=C3

Molecular Formula

C22H26N2O

Molecular Weight

334.45

References & Citations

[1]Le Foll B, et al. Dopamine D3 receptor ligands block nicotine-induced conditioned place preferences through a mechanism that does not involve discriminative-stimulus or antidepressant-like effects. Neuropsychopharmacology. 2005;30 (4) :720-730.